Professor Paul Dimitri, Professor of Child Health, Director of Research and Innovation at Sheffield Children’s, Consultant in Paediatric Endocrinology, and Director of NIHR Children and Young People MedTech Co-operative said:
“Research is a key component in the response to the current pandemic and I am proud that the team at Sheffield Children’s is able to support many research studies from across the UK.
“Fortunately it appears that the majority of children and young people that contract COVID-19 only appear to present with mild symptoms, but we continue to undertake research to understand how this virus affects the paediatric population. However, there is growing evidence that a small number of children are experiencing a more severe response to the virus, known as paediatric multi-system inflammatory syndrome. Sheffield Children’s is taking part in research projects to better understand this condition, in order to assist prevention and treatment.
“In our usual working environment, our team of experts in children’s conditions work hard to develop medicines, treatments and new health technology for children, working with partners locally, nationally and internationally to do so. Now we are able to use the skills from our colleagues and information provided by patients, families and staff at Sheffield Children’s to help inform the national picture of the COVID-19 outbreak and care for both children and adults, which will be incredibly valuable insight to help us move forward.”